Goldenwell Biotech, Inc. SEC filings GWLL

Goldenwell Biotech, Inc. has 85 filings in SEC EDGAR's recent list, going back to Feb 21, 2020. Its latest annual report, Form 10-K, was filed on Jul 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 9, 2026 (officer or director change). The company's fiscal year ends on December 31.

Goldenwell Biotech, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Oct 9, 2026 Oct 8, 2026
8-K Current report
Auditor change
Sep 29, 2026 Sep 27, 2026
8-K Current report
Restatement
May 27, 2026 May 19, 2026
8-K Current report
Auditor change
Aug 19, 2025 Jul 24, 2025
8-K Current report
Auditor change
Jan 23, 2025 Jan 23, 2025
8-K Current report
Auditor change
Nov 15, 2024 Nov 13, 2024
8-K Current report
Auditor change
May 20, 2024 May 15, 2024
8-K Current report
Auditor change
Sep 9, 2021 Sep 8, 2021

Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Food and Kindred Products (SIC 2000)
Listed as
GWLL (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Solon, OH
SEC filer status
, Emerging growth company
SEC CIK
1800373

Other Food and Kindred Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.